425
Participants
Start Date
December 31, 2008
Primary Completion Date
October 31, 2011
Study Completion Date
December 31, 2011
nevirapine
Nevirapine 200 mg twice daily or 400 mg once daily per os during 96 weeks
ritonavir-boosted Lopinavir
ritonavir-boosted lopinavir 800/200 mg once daily or 400/100 mg twice daily per os during 96 weeks
Tenofovir/emtricitabine
tenofovir 300 mg/emtricitabine 200 mg fixed-dose combination once daily, per os for 96 weeks
Zidovudine/lamivudine
zidovudine 300 mg/lamivudine 150 mg twice daily fixed-dose generic combination, per os for 96 weeks
Cliniques Universitaires de Lubumbashi, Lubumbashi
Collaborators (2)
University of Liege
OTHER
Ministry of Public Health, Democratic Republic of the Congo
OTHER_GOV
Pierre and Marie Curie University
OTHER
University Paris 7 - Denis Diderot
OTHER
Gilead Sciences
INDUSTRY
Abbott
INDUSTRY
Centre Hospitalier Universitaire Saint Pierre
OTHER